1. Home
  2. SNY vs SBUX Comparison

SNY vs SBUX Comparison

Compare SNY & SBUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNY
  • SBUX
  • Stock Information
  • Founded
  • SNY 1994
  • SBUX 1971
  • Country
  • SNY France
  • SBUX United States
  • Employees
  • SNY N/A
  • SBUX N/A
  • Industry
  • SNY Biotechnology: Pharmaceutical Preparations
  • SBUX Restaurants
  • Sector
  • SNY Health Care
  • SBUX Consumer Discretionary
  • Exchange
  • SNY Nasdaq
  • SBUX Nasdaq
  • Market Cap
  • SNY 116.5B
  • SBUX 105.8B
  • IPO Year
  • SNY N/A
  • SBUX 1992
  • Fundamental
  • Price
  • SNY $48.70
  • SBUX $94.43
  • Analyst Decision
  • SNY Buy
  • SBUX Buy
  • Analyst Count
  • SNY 2
  • SBUX 26
  • Target Price
  • SNY $62.50
  • SBUX $97.08
  • AVG Volume (30 Days)
  • SNY 2.1M
  • SBUX 8.8M
  • Earning Date
  • SNY 07-24-2025
  • SBUX 07-29-2025
  • Dividend Yield
  • SNY 3.31%
  • SBUX 2.58%
  • EPS Growth
  • SNY 39.56
  • SBUX N/A
  • EPS
  • SNY 5.45
  • SBUX 2.75
  • Revenue
  • SNY $48,817,552,946.00
  • SBUX $36,347,300,000.00
  • Revenue This Year
  • SNY $3.39
  • SBUX $3.93
  • Revenue Next Year
  • SNY $7.05
  • SBUX $6.17
  • P/E Ratio
  • SNY $17.56
  • SBUX $34.35
  • Revenue Growth
  • SNY N/A
  • SBUX N/A
  • 52 Week Low
  • SNY $45.80
  • SBUX $71.55
  • 52 Week High
  • SNY $60.12
  • SBUX $117.46
  • Technical
  • Relative Strength Index (RSI)
  • SNY 43.32
  • SBUX 61.41
  • Support Level
  • SNY $47.64
  • SBUX $90.33
  • Resistance Level
  • SNY $49.37
  • SBUX $95.86
  • Average True Range (ATR)
  • SNY 0.68
  • SBUX 2.14
  • MACD
  • SNY 0.14
  • SBUX 0.04
  • Stochastic Oscillator
  • SNY 30.56
  • SBUX 74.41

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in vaccines, immunology, oncology, cardiovascular disease, diabetes, and over-the-counter treatments. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing about 30% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

About SBUX Starbucks Corporation

Starbucks is one of the most widely recognized restaurant brands in the world, operating more than 40,000 stores across more than 80 countries at the end of March 2025. The firm operates in three segments: North America, international markets, and channel development (grocery and ready-to-drink beverage). The coffee chain generates revenue from company-operated stores, royalties, sales of equipment and products to license partners, ready-to-drink beverages, packaged coffee sales, and single-serve products.

Share on Social Networks: